BG107642A - Triazole derivatives and pharmaceutical compositions comprising them - Google Patents
Triazole derivatives and pharmaceutical compositions comprising themInfo
- Publication number
- BG107642A BG107642A BG107642A BG10764203A BG107642A BG 107642 A BG107642 A BG 107642A BG 107642 A BG107642 A BG 107642A BG 10764203 A BG10764203 A BG 10764203A BG 107642 A BG107642 A BG 107642A
- Authority
- BG
- Bulgaria
- Prior art keywords
- pharmaceutical compositions
- triazole derivatives
- compounds
- polymorphs
- solvates
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102100021942 C-C motif chemokine 28 Human genes 0.000 abstract 1
- 101000897477 Homo sapiens C-C motif chemokine 28 Proteins 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0004153A HUP0004153A3 (en) | 2000-10-26 | 2000-10-26 | 3-amino-triazole derivatives with medicinal applicability, process for their preparation and pharmaceutical compositions containing them and their use |
| FR0013728A FR2815963B1 (fr) | 2000-10-26 | 2000-10-26 | Nouveaux derives du triazole et les compositions pharmaceutiques les contenant |
| PCT/EP2001/012984 WO2002034743A1 (en) | 2000-10-26 | 2001-10-25 | Triazole derivatives and pharmaceutical compositions comprising them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG107642A true BG107642A (en) | 2003-11-28 |
Family
ID=89978697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG107642A BG107642A (en) | 2000-10-26 | 2003-03-18 | Triazole derivatives and pharmaceutical compositions comprising them |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20040019091A1 (et) |
| EP (1) | EP1335914A1 (et) |
| JP (1) | JP2004512334A (et) |
| KR (1) | KR20030042035A (et) |
| CN (1) | CN1471525A (et) |
| AR (1) | AR031042A1 (et) |
| AU (1) | AU2002226330A1 (et) |
| BG (1) | BG107642A (et) |
| BR (1) | BR0114888A (et) |
| CA (1) | CA2420727A1 (et) |
| EA (1) | EA200300238A1 (et) |
| EE (1) | EE200300161A (et) |
| HR (1) | HRP20030330A2 (et) |
| IL (1) | IL155055A0 (et) |
| IS (1) | IS6734A (et) |
| NO (1) | NO20031841L (et) |
| NZ (1) | NZ524437A (et) |
| PL (1) | PL365328A1 (et) |
| SK (1) | SK5172003A3 (et) |
| WO (1) | WO2002034743A1 (et) |
| YU (1) | YU18803A (et) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005035793A2 (en) * | 2003-10-09 | 2005-04-21 | Decode Genetics Ehf. | Cckar markers and haplotypes associated with extreme weight conditions |
| JP4892915B2 (ja) * | 2005-10-04 | 2012-03-07 | 大日本印刷株式会社 | エパルレスタット製造法 |
| US8703761B2 (en) * | 2008-07-15 | 2014-04-22 | Novartis Ag | Organic compounds |
| US20130179356A1 (en) * | 2012-01-05 | 2013-07-11 | General Electric Company | Method and system for maintenance of turbomachinery |
| CN104130243B (zh) * | 2014-07-08 | 2016-05-25 | 河北美星化工有限公司 | 取代对卤苯基三唑环取代氟化烟酰胺化合物及合成方法 |
| KR20220150270A (ko) | 2019-10-07 | 2022-11-10 | 칼리오페, 인크. | Gpr119 효능제 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2701708B1 (fr) * | 1993-02-19 | 1995-05-19 | Sanofi Elf | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
| FR2703995B1 (fr) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant. |
| FR2763337B1 (fr) * | 1997-05-13 | 1999-08-20 | Sanofi Sa | Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant |
-
2001
- 2001-10-25 EP EP01988716A patent/EP1335914A1/en not_active Withdrawn
- 2001-10-25 CA CA002420727A patent/CA2420727A1/en not_active Abandoned
- 2001-10-25 KR KR10-2003-7005772A patent/KR20030042035A/ko not_active Application Discontinuation
- 2001-10-25 JP JP2002537734A patent/JP2004512334A/ja not_active Withdrawn
- 2001-10-25 AR ARP010104990A patent/AR031042A1/es unknown
- 2001-10-25 AU AU2002226330A patent/AU2002226330A1/en not_active Abandoned
- 2001-10-25 YU YU18803A patent/YU18803A/sh unknown
- 2001-10-25 PL PL01365328A patent/PL365328A1/xx not_active Application Discontinuation
- 2001-10-25 CN CNA018181236A patent/CN1471525A/zh active Pending
- 2001-10-25 BR BR0114888-5A patent/BR0114888A/pt not_active Application Discontinuation
- 2001-10-25 WO PCT/EP2001/012984 patent/WO2002034743A1/en not_active Application Discontinuation
- 2001-10-25 US US10/398,858 patent/US20040019091A1/en not_active Abandoned
- 2001-10-25 EE EEP200300161A patent/EE200300161A/et unknown
- 2001-10-25 SK SK517-2003A patent/SK5172003A3/sk unknown
- 2001-10-25 EA EA200300238A patent/EA200300238A1/ru unknown
- 2001-10-25 IL IL15505501A patent/IL155055A0/xx unknown
- 2001-10-25 NZ NZ524437A patent/NZ524437A/en not_active Application Discontinuation
-
2003
- 2003-02-28 IS IS6734A patent/IS6734A/is unknown
- 2003-03-18 BG BG107642A patent/BG107642A/xx unknown
- 2003-04-24 NO NO20031841A patent/NO20031841L/no not_active Application Discontinuation
- 2003-04-28 HR HR20030330A patent/HRP20030330A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| YU18803A (sh) | 2006-05-25 |
| EP1335914A1 (en) | 2003-08-20 |
| NZ524437A (en) | 2004-10-29 |
| IS6734A (is) | 2003-02-28 |
| KR20030042035A (ko) | 2003-05-27 |
| HRP20030330A2 (en) | 2003-06-30 |
| AU2002226330A1 (en) | 2002-05-06 |
| CA2420727A1 (en) | 2002-05-02 |
| EE200300161A (et) | 2003-06-16 |
| NO20031841L (no) | 2003-06-19 |
| CN1471525A (zh) | 2004-01-28 |
| US20040019091A1 (en) | 2004-01-29 |
| WO2002034743A1 (en) | 2002-05-02 |
| AR031042A1 (es) | 2003-09-03 |
| NO20031841D0 (no) | 2003-04-24 |
| JP2004512334A (ja) | 2004-04-22 |
| PL365328A1 (en) | 2004-12-27 |
| IL155055A0 (en) | 2003-10-31 |
| EA200300238A1 (ru) | 2003-10-30 |
| SK5172003A3 (en) | 2003-10-07 |
| BR0114888A (pt) | 2003-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02012033A (es) | Derivados de 2-aminocarbonil-9h-purina. | |
| MXPA03004549A (es) | Derivados de 3-arilindola y su uso como agonistas del receptor cb2. | |
| IL142649A0 (en) | Azole derivatives | |
| BG106569A (en) | Purine derivatives | |
| BG106340A (en) | Substituted oxoazaheterocyclyl compounds | |
| MXPA05009985A (es) | Ligandos de receptores de canabinoides. | |
| EP1496892A4 (en) | 1H-BENZO (F) INDAZOL-5-YL DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS | |
| HK1070054A1 (en) | Arylsulfonyl derivatives with5-ht6 receptor affinity | |
| JO2371B1 (en) | 4-phenyl-pyridine derivatives | |
| MXPA04004674A (es) | Ligados de los receptors de los canabinodies. | |
| BG106906A (en) | Purine derivatives | |
| BG106567A (en) | Purine derivatives | |
| BG106289A (en) | Purine derivatives | |
| ATE316083T1 (de) | Adamantanderivate | |
| MY122392A (en) | Adamantane derivatives of use of p2x7 receptor antagonists, a process for their preparation, pharmaceutical compositions containing them and a process for preparing the pharmaceutical compositions | |
| BG107171A (en) | Purine derivatives | |
| MY141559A (en) | Triazole derivatives as tachykinin receptor antagonists | |
| MXPA02009706A (es) | Metodo para sintesis de perindopril y sus sales farmaceuticamente aceptables. | |
| YU80902A (sh) | Novi indolin-2-on derivati, njihovo dobijanje i farmaceuski oblici koji ih sadrže | |
| MY140235A (en) | New benzimidazole derivatives | |
| DE602004009200D1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| MXPA03000161A (es) | Compuestos novedosos los cuales tienen actividad antiinflamatoria, proceso para su preparacion y composiciones farmaceuticas que las contienen. | |
| MXPA05011176A (es) | Derivados de carboxamida como agentes antidiabeticos. | |
| MY138826A (en) | 2,7-substituted indoles | |
| MXPA03001610A (es) | Derivados de acido oxazolil-arilpropionico y su uso como agonistas de los receptores activados por proliferadores de peroxisomas. |